Publications

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.

Jensen I, Helm T, Cyr P. Impact of dysphagia on U.S. hospital charges in patients with comorbid conditions. Abstract PGI9, ISPOR 14th Annual European Congress, 2011.

Jensen I, Helm T, Cyr P. Impact of complications from dysphagia on hospital charges in the United States. Abstract PGI7, ISPOR 14th Annual European Congress, 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastases among breast, lung, and prostate cancer patients. Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Prevalence of bone metastasis after breast, lung, and prostate cancers: A systematic and quantitative review of the literature. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Lau EC, Steffey D, Legg JC, Watson HN, Mowat FS, Kelsh MA. The problem of missing data: Using imputation methods to facilitate oncology outcomes research. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Mowat FS, Lau EC, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, Collins HL, et al. Assessing the comparability of EMR information to patient registry and health claims data. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Jiang X, Zwica L, Knutson K, Towey T, Hedgeman E, Franzblau A, Chen Q, Lee S-Y, Sima C, Gillespie BW, Adriaens P, Demond A, Lepkowski J, Ward B, Ladronka K, Olson K, Sinibaldi J, Chang S-C, Gwinn D, Swan S, Garabrant D. Measurements of household dust concentrations of PCDDs, PCDFs, and PCBs from a community in Michigan, USA. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.

Jiang X, Knutson K, Zwica L, Lee S-Y, Chen Q, Hong B, Zhong X, Hao W, Towey T, Gillespie BW, Demond A, Adriaens P, Lepkowski J, Franzblau A, Garabrant D. The University of Michigan Dioxin Exposure Study: Predictors of household dust PCDD, PCDF, and PCB concentrations. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.